The intravenous options for MRSA are generally limited to vancomycin ... inhaled and intravenous antibiotic agents. Chronic use of aerosolized antibiotics such as tobramycin or colistin, as ...

Vancomycin is the preferred IV treatment option for MRSA strains in adults who are allergic to penicillin. It is important to ...

Resistance development of MRSA has become a global health problem. New resistance types, such as vancomycin-resistant S. aureus, have been recently developed. Novel antibiotics, such as linezolid ...

MRSA (pronounced MUR-suh), seen here as purple spheres, is the abbreviation for methicillin-resistant Staphylococcus aureus, an antibiotic-resistant bacterium that can cause a severe infection in ...

In line with that, new research has shown a daily dose of epidermicin NI01 – an antibiotic compound developed by University ...

When that happens, your infection will be said to be antibiotic resistant, and your physician will have to prescribe a different drug to combat it. MRSA: The Spread of Drug Resistance In fact ...

Both drugs are effective against methicillin-resistant Staphylococcus aureus (MRSA) and other skin infections. Dalvance is an injectable drug and is the first drug to be approved via FDA’s new ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...

At the moment, there are antibiotics that can be used to treat skin infections caused by MRSA and other Staphylococcus strains, but these can come with a number of unpleasant side effects.